AMFI In Talks With Fintechs To Conduct Stress Tests Across MF Schemes, Says Chief Chalasni
The Association of Mutual Funds in India plans to conduct stress tests across all mutual fund schemes, said Chief Executive Venkat Nageswar Chalasani.
“In February, we came out with stress tests on small and mid cap spaces. Now we are planning to do a similar stress testing for all schemes,” Chalasani said at India Fintech Forum's IFTA 2024.
With this initiative, the industry body will be able to bring out new models and are in talks with several financial technology companies to conduct stress tests for the entire industry, he said.
This will further help the industry body with efficient disclosures.

Venkat Chalasani, chief executive of Association of Mutual Funds in India. (Photographer: Vijay Sartape/NDTV Profit)
On retailing debt schemes, Chalasni said that AMFI has put in place a set of recommendations in front of the government to bring back the indexation benefits that were withdrawn last year.
“The corporate bond market has to evolve and for that to happen, you need to have some taxation benefits,” he told NDTV Profit on the sidelines of the event.
In March 2023, the finance ministry made amendments to the finance bill 2023, removing long term capital gains and taxation benefits on income from debt mutual fund schemes.
Speaking of the slowdown in recent equity inflows, he said that this is a dip because of a rise in lump sum investments. However, overall the path for long-term looks intact.
Inflows to equity mutual funds in November declined 14% to Rs 35,943 crore against Rs 41,886 crore in October, according to latest AMFI data.
Overall, Chalasni emphasised on the support from the fintech sector and said that the opportunity on innovation and technology still remains untapped.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.